Empower Clinics says Kai Medical Lab pulls in C$1 million coronavirus test processing order from film production client

Empower Clinics Inc (CSE:CBDT) (OTCQB:EPWCF) announced Monday that its Kai Medical Laboratory has received a record coronavirus test order expected to be worth more than C$1 million from a film and television production entity.

The order includes 9,000 24-hour RT-PCR coronavirus tests, which Kai will process over a four-month period. The client is now a repeat customer, the company said, that previously paid for 1,000 tests to be processed over 30 days in early October. 

The lab, acquired on October 6, has been busy.

READ: Empower Clinic’s Kai Medical Laboratory achieves record coronavirus test processing in October

“Just three days ago we were happy to inform our shareholders that Kai had achieved a record month in October with 1,375 units, as well as signed numerous new commercial testing contracts, the details of which were to be provided in subsequent press releases. Today’s contract is not one of those contracts,” Empower CEO Steve McAuley said in a statement.

“We were informed of this contract at the close of business on Friday. As I said on Friday, the magnitude of KAI’s growth and success can not be overstated.”

Going forward, the plan is to ramp up processing even further, particularly in the film and television production industry, which has been significantly impacted by the coronavirus.

“Though we are very happy with today’s record order announcement, these 9,000 tests represent only a fraction of the lab’s capacity of 4,000 COVID-19 RT-PCR tests per day,” McAuley said. “It is our intention to build on this big success and continue ramping up growth significantly through 2020 and well into 2021.”

To further assist with COVID-19 testing, Kai has developed a pair of programs in Texas and Arizona. The first program is a direct-to-consumer program that leverages the ability of healthcare providers to order and administer both the RT-PCR test and the antibody test, which increases the ability of the general population to be tested. The second is an Employer COVID-19 Compliance Program (ECCP) for business owners and employer groups, enabling them to test and monitor their employees.

Contact Andrew Kessel at [email protected]

Follow him on Twitter @andrew_kessel

Story by ProactiveInvestors